It is a new medice for those who are going through menopause and men to treat advanced breast cancer. It is called PIQRAY
The first and only treatment used in combination with the medicine fulvestrant to treat women who have gone through menopause, and men, to treat HR+, HER2- advanced or metastatic breast cancer (mBC) with an abnormal PIK3CA gene whose disease has progressed on or after endocrine (hormone) therapy.
- A biomarker-driven treatment approach, which means that your health care provider will test your cancer for an abnormal "PIK3CA" gene to make sure that PIQRAY is right for you.
- For more information click here
